Familial and sporadic hypertrophic cardiomyopathy: Differences and similarities in a genotyped population. A long follow-up study;Miocardiopatia hipertrófica familiar e esporádica: Diferenças e semelhanças numa população com estudo genético e longo tempo de seguimento clínico

Revista Portuguesa de Cardiologia

Volumn 27, Issue 2, 2008, Pages 147-173

  Brito, Dulce ^a,c   Richard, Pascale ^b   Komajda, Michel ^b   Madeira, Hugo ^a  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

Clinical follow up; Familial hypertrophic cardiomyopathy; Prognosis; Sarcomeric gene mutations; Sporadic hypertrophic cardiomyopathy

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOTYPE; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MORTALITY; PHENOTYPE; POPULATION RESEARCH; SARCOMERE; SEQUENCE ANALYSIS; SEX DIFFERENCE; SUDDEN DEATH;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARDIOMYOPATHY, HYPERTROPHIC, FAMILIAL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 42249090222     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Clark CE, Henry WL, Epstein SE. Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis. N Engl J Med 1973; 289(14):709-14.
2. Maron BJ, Nichols PF, III, Pickle LW, Wesley YE, Mulvihill JJ. Patterns of inheritance in hypertrophic cardiomyopathy: assessment by M-mode and two-dimensional echocardiography. Am J Cardiol 1984; 53(8):1087-1094.
3. Haugland H, Ohm OJ, Boman H, Thorsby E. Hypertrophic cardiomyopathy in three generations of a large Norwegian family. A clinical, echocardiographic, and genetic study. Br Heart J 1986; 55(2):168-175.
4. Maron BJ, Tajik AJ, Ruttenberg HD, Graham TP, Atwood GF, Victorica BE et al. Hypertrophic cardiomyopathy in infants: clinical features and natural history. Circulation 1982; 65(1):7-17.
5. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2003; 24(21):1965-1991.
6. Charron P, Dubourg O, Desnos M, Bouhour JB, Isnard R, Hagege A et al. Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped children. Eur Heart J 1998; 19(9):1377-1382.
7. Charron P, Forissier JF, Amara ME, Dubourg O, Desnos M, Bouhour JB et al. Accuracy of European diagnostic criteria for familial hypertrophic cardiomyopathy in a genotyped population. Int J Cardiol 2003; 90(1):33-38.
8. Dubourg O, Isnard R, Hagege A, Jondeau G, Desnos M, Sacrez A et al. Doppler echocardiography in familial hypertrophic cardiomyopathy: the French Cooperative Study. Echocardiography 1995; 12(3):235-241.
9. Charron P, Dubourg O, Desnos M, Isnard R, Hagege A, Bonne G et al. Genotype-phenotype correlations in familial hypertrophic cardiomyopathy. A comparison between mutations in the cardiac protein-C and the beta-myosin heavy chain genes. Eur Heart J 1998; 19(1):139-145.
10. Spirito P, Bellone P, Harris KM, Bernabo P, Bruzzi P, Maron BJ. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med 2000; 342(24):1778-1785.
11. Olivotto I, Gistri R, Petrone P, Pedemonte E, Vargiu D, Cecchi F. Maximum left ventricular thickness and risk of sudden death in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2003; 41(2):315-321.
12. Henry WL, DeMaria A, Gramiak R, King DL, Kisslo JA, Popp RL et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation 1980; 62(2):212-217.
13. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measure-ments. Circulation 1978; 58(6):1072-1083.
14. Panza JA, Pétrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992; 19(1):91-99.
15. Cooper JW, Nanda NC, Philpot EF, Fan P. Evaluation of valvular regurgitation by color Doppler. J Am Soc Echocardiogr 1989; 2(1):56-66.
16. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989; 2(5):358-367.
17. Maron BJ, Gottdiener JS, Epstein SE. Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients. Am J Cardiol 1981; 48(3):418-428.
18. Shapiro LM, McKenna WJ. Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study. J Am Coll Cardiol 1983; 2(3):437-444.
19. Spirito P, Maron BJ. Relation between extent of left ventricular hypertrophy and occurrence of sudden cardiac death in hypertrophic cardiomyopathy. J Am Coll Cardiol 1990; 15(7):1521-1526.
20. Ciro E, Nichols PF, III, Maron BJ. Heterogeneous morphologic expression of genetically transmitted hypertrophic cardiomyopathy. Two-dimensional echocardiographic analysis. Circulation 1983; 67(6):1227-1233.
21. Maron BJ, Bonow RO, Seshagiri TN, Roberts WC, Epstein SE. Hypertrophic cardiomyopathy with ventricular septal hypertrophy localized to the apical region of the left ventricle (apical hypertrophic cardiomyopathy). Am J Cardiol 1982; 49(8):1838-1848.
22. Richard P, Charron P, Carrier L, Ledeuil C, Cheav T, Pichereau C et al. Hypertrophic cardiomyopathy: distribution of disease genes, spectrum of mutations, and implications for a molecular diagnosis strategy. Circulation 2003; 107(17):2227-2232.
23. Hollman A, Goodwin JF, Teare D, Renwick JW. A family with obstructive cardiomyopathy (asymmetrical hypertrophy). Br Heart J 1960; 22:449-56.
24. Pare JAP, Fraser RG, Pirozynsky WY, Shanks JB, Stubington D. Hereditary cardiovascular dysplasia. A form of familial cardiomyopathy. Am J Med 1961;31:37-62.
25. Horlick L, Petkovich NJ, Bolton CF. Idiopathic hypertrophic subvalvular stenosis. A study of a family involving four generations. Clinical, hemodynamic and pathologic observations. Am J Cardiol 1966; 17:411-418.
26. Frank S, Braunwald E. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation 1968; 37(5):759-788.
27. Littler WA. Twin studies in hypertrophic cardiomyopathy. Br Heart J 1972; 34(11):1147-1151.
28. Goodwin JF. Hypertrophic cardiomyopathy: a disease in search of its own identity. Am J Cardiol 1980; 45(1):177-180.
29. Maron BJ, Epstein SE. Hypertrophic cardiomyopathy: a discussion of nomenclature. Am J Cardiol 1979; 43(6):1242-1244.
30. Niimura H, Patton KK, McKenna WJ, Soults J, Maron BJ, Seidman JG et al. Sarcomere protein gene mutations in hypertrophic cardiomyopathy of the elderly. Circulation 2002; 105(4):446-451.
31. Watkins H, Thierfelder L, Hwang DS, McKenna W, Seidman JG, Seidman CE. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations. J Clin Invest 1992; 90(5):1666-1671.
32. Forissier JF, Richard P, Briault S, Ledeuil C, Dubourg O, Charbonnier B et al. First description of germline mosaicism in familial hypertrophic cardiomyopathy. J Med Genet 2000; 37(2):132-134.
33. Maron BJ, Bonow RO, Cannon RO, III, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy (1). N Engl J Med 1987; 316(13):780-789.
34. Maron BJ, Niimura H, Casey SA, Soper MK, Wright GB, Seidman JG et al. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations. J Am Coll Cardiol 2001; 38(2):315-321.
35. Greaves SC, Roche AH, Neutze JM, Whitlock RM, Veale AM. Inheritance of hypertrophic cardiomyopathy: a cross sectional and M mode echocardiographic study of 50 families. Br Heart J 1987; 58(3):259-266.
36. Van Driest SL, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Yield of genetic testing in hypertrophic cardiomyopathy. Mayo Clin Proc 2005; 80(6):739-744.
37. Erdmann J, Daehmlow S, Wischke S, Senyuva M, Werner U, Raible J et al. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy. Clin Genet 2003; 64(4):339-349.
38. Van Driest SL, Ellsworth EG, Ommen SR, Tajik AJ, Gersh BJ, Ackerman MJ. Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy. Circulation 2003; 108(4):445-451.
39. Jaaskelainen P, Soranta M, Miettinen R, Saarinen L, Pihlajamaki J, Silvennoinen K et al. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population. J Am Coll Cardiol 1998; 32(6):1709-1716.
40. Jaaskelainen P, Miettinen R, Silvennoinen K, Vauhkonen I, Laakso M, Kuusisto J. The cardiac troponin I gene is not associated with hypertrophic cardiomyopathy in patients from eastern Finland. J Mol Cell Cardiol 1999; 31(11):2031-2036.
41. Jaaskelainen P, Kuusisto J, Miettinen R, Karkkainen P, Karkkainen S, Heikkinen S et al. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland. J Mol Med 2002; 80(7):412-422.
42. Karkkainen S, Peuhkurinen K, Jaaskelainen P, Miettinen R, Karkkainen P, Kuusisto J et al. No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy. Am Heart J 2002; 143(6):E6.
43. Morner S, Richard P, Kazzam E, Hellman U, Hainque B, Schwartz K et al. Identification of the genotypes causing hypertrophic cardiomyopathy in northern Sweden. J Mol Cell Cardiol 2003; 35(7):841-849.
44. Garcia-Castro M, Reguero JR, Batalla A, Diaz-Molina B, Gonzalez P, Alvarez V et al. Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. Clin Chem 2003; 49(8):1279-1285.
45. Wilcken DE. Overview of inherited metabolic disorders causing cardiovascular disease. J Inherit Metab Dis 2003; 26(2-3):245-257.
46. Desnick RJ, Brady R, Barranger J, Collins AJ, Germain DP, Goldman M et al. Fabry disease, an under-recognized multisystemic disorder: expert recommendations for diagnosis, management, and enzyme replacement therapy. Ann Intern Med 2003; 138(4):338-346.
47. Schiffmann R, Kopp JB, Austin HA, III, Sabnis S, Moore DF, Weibel T et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 2001; 285(21):2743-2749.
48. Eng CM, Guffon N, Wilcox WR, Germain DP, Lee P, Waldek S et al. Safety and efficacy of recombinant human alpha-galactosidase A - replacement therapy in Fabry's disease. N Engl J Med 2001; 345(1):9-16.
49. Nakao S, Takenaka T, Maeda M, Kodama C, Tanaka A, Tahara M et al. An atypical variant of Fabry's disease in men with left ventricular hypertrophy. N Engl J Med 1995; 333(5):288-93.
50. Sachdev B, Takenaka T, Teraguchi H, Tei C, Lee P, McKenna WJ et al. Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy. Circulation 2002; 105(12):1407-1411.
51. Elleder M, Bradova V, Smid F, Budesinsky M, Harzer K, Kustermann-Kuhn B et al. Cardiocyte storage and hypertrophy as a sole manifestation of Fabry's disease. Report on a case simulating hypertrophic non-obstructive cardiomyopathy. Virchows Arch A Pathol Anat Histopathol. 1990; 417(5):449-55.
52. Bonvini RF, Camenzind E. Left ventricular hypertrophy: diagnostic pitfalls. Swiss Med Wkly 2004; 134(19-20):289-292.